Trickey, Adam T. May, Margaret Vehreschild, Janne Obel, Niels Gill, Michael John Crane, Heidi Boesecke, Christoph Samji, Hasina Grabar, Sophie Cazanave, Charles Cavassini, Matthias Shepherd, Leah d’Arminio Monforte, Antonella Smit, Colette Saag, Michael Lampe, Fiona Hernando, Vicky Montero, Marta Zangerle, Robert C. Justice, Amy Sterling, Timothy Miro, Jose Ingle, Suzanne A. C. Sterne, Jonathan Characteristics of patients followed from 10 years after start of ART who died, were lost to follow up (LTFU) or remained in the study until end of follow up. <p>Characteristics of patients followed from 10 years after start of ART who died, were lost to follow up (LTFU) or remained in the study until end of follow up.</p> combination antiretroviral therapy;CD 4 count;estimate mortality rates;antiretroviral therapy;Antiretroviral Therapy Objectives;RNA;injection drug use;Conclusions Viral replication;AIDS;Antiretroviral Therapy Cohort Collaboration;North American HIV cohort studies;drug use transmission 2016-08-15
    https://plos.figshare.com/articles/dataset/Characteristics_of_patients_followed_from_10_years_after_start_of_ART_who_died_were_lost_to_follow_up_LTFU_or_remained_in_the_study_until_end_of_follow_up_/3588879
10.1371/journal.pone.0160460.t002